Back to How I Healed Graves’ Disease Naturally | My Exact
Claim
Strong Support
correlational
Analysis v3

People with low selenium levels have more severe eye symptoms from Graves' disease.

59
Pro
0
Against

Mechanism

Synthesis from 2 studies

How it works

Low selenium means the eye tissues can't fight off harmful chemicals, which triggers swelling and redness. Adding selenium restores the body's natural defenses, stops the damage, and calms the immune response, reducing eye symptoms.

Most probable mechanism

In Simple Terms

When selenium levels are low, the body cannot make enough protective proteins that neutralize harmful chemicals in the eye tissues. This allows damage to build up, which triggers immune cells to attack the area around the eyes, causing swelling, redness, and pain. Adding selenium restores these protective proteins, stops the damage, and calms the immune response, reducing swelling and symptoms.

Causal chain
1

Selenium is absorbed from the gut and transported to orbital tissues via selenoprotein P

Supported by evidence
which leads to
2

Selenium is incorporated into selenoproteins including glutathione peroxidases and thioredoxin reductases in orbital fibroblasts and immune cells

Supported by evidence
which leads to
3

Selenoproteins reduce hydrogen peroxide and lipid peroxides, lowering oxidative stress in orbital tissues

Supported by evidence
which leads to
4

Reduced oxidative stress inhibits NF-κB signaling in orbital fibroblasts, decreasing production of IL-6, TNF-α, and IFN-γ

Supported by evidence
which leads to
5

Lower cytokine levels reduce recruitment and activation of T cells and macrophages in orbital fat and muscle

Supported by evidence
which leads to
6

Decreased immune cell infiltration and cytokine activity reduce vascular permeability, edema, and tissue remodeling in orbital soft tissues

Verified by multiple studies

Evidence from Studies

Supporting (2)

59

Community contributions welcome

59

Effect of Selenium Supplementation on Mild Graves’ Ophthalmopathy at a Tertiary Hospital – a Six-Month, Open-Labelled, Assessor-Masked, Randomized Controlled Trial

Randomized Controlled Trial
Human
53

6662 Effect of Selenium Supplementation on Mild Graves’ Ophthalmopathy at a Tertiary Hospital - A Six-Month Open-Labelled, Assessor-Masked, Randomized-Controlled Trial

Randomized Controlled Trial
Human

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Sign up to see full verdict

Similar Assertions

In patients with mild Graves’ ophthalmopathy, taking 200 mcg of selenium daily for six months is associated with a reduction in swelling of the eye tissues and improved clinical activity scores compared to those not taking selenium.

59
0
85%

In patients with mild Graves’ ophthalmopathy, taking 200 mcg of selenium daily for six months is associated with the absence of eyelid redness in all treated individuals, while 9.52% of untreated individuals experienced eyelid redness.

59
0
84%

There is no clear evidence that taking selenium supplements improves key outcomes for people with Graves' disease, such as reducing relapses, improving quality of life, or easing eye symptoms.

39
0
83%

In patients with mild, active Graves' orbitopathy lasting less than seven months, selenium supplementation may be linked to better quality of life and fewer eye symptoms, but these findings are based on one study and have not been confirmed by others.

39
0
83%

In adults with mild Graves’ ophthalmopathy, taking selenium supplements for six months results in a measurable reduction in swelling of the caruncle and plical tissues compared to standard care alone.

53
0
83%

Related Content